OncoZenge AB (publ) (FRA:8LY)
Germany · Delayed Price · Currency is EUR 0.4910
-0.0045 (-0.91%)
Last updated: Dec 2, 2025, 8:22 AM CET
OncoZenge AB Revenue
OncoZenge AB had revenue of 2.00K SEK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 2.78M, up 69,475.00% year-over-year. In the year 2024, OncoZenge AB had annual revenue of 1,000.00, down -66.67%.
Revenue (ttm)
2.78M SEK
Revenue Growth
+69,475.00%
P/S Ratio
25.45
Revenue / Employee
2.78M SEK
Employees
1
Market Cap
6.41M EUR
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000.00 | -2.00K | -66.67% |
| Dec 31, 2023 | 3.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |